OTCMKTS:FPMI FluoroPharma Medical (FPMI) Stock Price, News & Analysis → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free FPMI Stock Alerts $0.0001 0.00 (0.00%) (As of 05/10/2024) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0002Volume5,000 shsAverage Volume37,500 shsMarket Capitalization$2,758.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). About FluoroPharma Medical Stock (OTCMKTS:FPMI)FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.Read More FPMI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FPMI Stock News HeadlinesJuly 19, 2023 | msn.comNew 'Fluoro Fentanyl' considered 5 times more potent than normal dose, report saysAugust 30, 2022 | reuters.comFluoroPharma Medical IncJanuary 19, 2022 | nasdaq.comFluoroPharma Medical Inc (FPMI)See More Headlines Company Calendar Last Earnings8/14/2015Today5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:FPMI CUSIPN/A CIK1402785 Webwww.fluoropharma.com Phone(973) 744-1565FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares27,580,000Free Float17,401,000Market Cap$2,758.00 OptionableNot Optionable BetaN/A Key ExecutivesDr. Thomas H. Tulip Ph.D. (Age 71)CEO, President & Director Comp: $320kMs. Tamara Rhein (Age 52)Chief Financial Officer Comp: $130kMr. Edward L. Lyons Jr.Vice President of DevelopmentKey CompetitorsBG MedicineOTCMKTS:BGMDHemagen DiagnosticsOTCMKTS:HMGNResponse GeneticsOTCMKTS:RGDXQ180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFFView All Competitors FPMI Stock Analysis - Frequently Asked Questions How have FPMI shares performed in 2024? FluoroPharma Medical's stock was trading at $0.0001 at the start of the year. Since then, FPMI stock has increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. How were FluoroPharma Medical's earnings last quarter? FluoroPharma Medical, Inc. (OTCMKTS:FPMI) issued its quarterly earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.01. What other stocks do shareholders of FluoroPharma Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET), AB Corporate Bond ETF (EYEG), Designer Brands (DBI), Capricorn Energy (CNE), Comcast (CMCSA), Casey's General Stores (CASY), Axos Financial (AX) and Argos Therapeutics (ARGSQ). How do I buy shares of FluoroPharma Medical? Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FPMI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding FluoroPharma Medical, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
